GSE163411
MDA-MB-231-LM2 cells treated with sudemycin D6 (SD6)
The objective is to identify gene expression patterns that occur after spliceosome inhibition in triple-negative breast cancer. Overall design: MDA-MB-231-LM2 cells were treated with vehicle (DMSO) or SD6 for 72 hours, in biological triplicate.